Avidia
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 1 Study of Safety and Biological Effects of C326, an Inhibitor of IL-6, in Crohn's Disease (NCT00353756) | Avidia | 2006-09-01 |
Track Avidia automatically
Every clearance here is in the API, with alerts when new ones post.